Apollon Formularies, plc (AQSE:APOL) is an international medical cannabis and medicinal mushroom pharmaceutical company which was one of the first companies, with THC-included products, permitted to become a publicly traded company in London, England, UK . The company specializes in developing medical cannabis and medicinal mushroom formulations for patient treatments by prescription and under the supervision of medical doctors. Apollon's products undergo rigorous scientific testing and the… Show more Apollon Formularies, plc (AQSE:APOL) is an international medical cannabis and medicinal mushroom pharmaceutical company which was one of the first companies, with THC-included products, permitted to become a publicly traded company in London, England, UK . The company specializes in developing medical cannabis and medicinal mushroom formulations for patient treatments by prescription and under the supervision of medical doctors. Apollon's products undergo rigorous scientific testing and the company collects patient data in clinical trial settings. Show less

Doc's Place International is company specializing in beautiful beachfront health and wellness resorts and spas to provide lodging for global medical tourism patients seeking natural therapeutics, including legal medical cannabis and medicinal mushroom treatment, by prescription and under the supervision of licensed physicians, with both long term and short term lodging options available in a beautiful healing environment. Doc's Place International's first such facility is in Negril, Jamaica… Show more Doc's Place International is company specializing in beautiful beachfront health and wellness resorts and spas to provide lodging for global medical tourism patients seeking natural therapeutics, including legal medical cannabis and medicinal mushroom treatment, by prescription and under the supervision of licensed physicians, with both long term and short term lodging options available in a beautiful healing environment. Doc's Place International's first such facility is in Negril, Jamaica where patients can receive treatment in a legal, medical, professional and safe environment under the supervision of licensed physicians. Current independent physicians that utilize the facility for their patients lodging specialize in neurosurgery, oncology, palliative care, surgery, psychiatry, dermatology and general practice. These physicians have additional special training and expertise in treating patients with medical cannabis and medical mushroom pharmaceuticals. Show less

Apollon Formularies Jamaica is a biotech and pharmaceutical company specializing in the production, intellectual property protection, and commercialization of legal medical cannabis and medicinal mushroom derived pharmaceuticals to be utilized by prescription under the supervision of licensed physicians in Jamaica. Apollon Formularies Jamaica also provides the opportunity to conduct clinical trials and patient outcomes data collection for medical and scientific studies on medical cannabis and… Show more Apollon Formularies Jamaica is a biotech and pharmaceutical company specializing in the production, intellectual property protection, and commercialization of legal medical cannabis and medicinal mushroom derived pharmaceuticals to be utilized by prescription under the supervision of licensed physicians in Jamaica. Apollon Formularies Jamaica also provides the opportunity to conduct clinical trials and patient outcomes data collection for medical and scientific studies on medical cannabis and medicinal mushroom products and devices. Apollon Formularies Jamaica, Ltd. is Federally legally licensed for Cultivation, Processing, Research and Development, and Retail (Therapeutic) in Jamaica. Show less

Stephen D. Barnhill M.D, Fellowship trained in Laboratory Medicine is a pioneer in machine learning and pattern recognition algorithms and an inventor on more than 80 international patents including neural networks (NN’s) and support vector machines (SVM’s) including the hallmark (SVM-RFE) technique. His patents were in the IP portfolio that won the first place MICO Award from MDB Capital, winning over IP portfolios from 1600 public companies. His NN patents were acquired by Johnson & Johnson… Show more Stephen D. Barnhill M.D, Fellowship trained in Laboratory Medicine is a pioneer in machine learning and pattern recognition algorithms and an inventor on more than 80 international patents including neural networks (NN’s) and support vector machines (SVM’s) including the hallmark (SVM-RFE) technique. His patents were in the IP portfolio that won the first place MICO Award from MDB Capital, winning over IP portfolios from 1600 public companies. His NN patents were acquired by Johnson & Johnson. He is an inventor on patents related to laboratory developed tests (LDT’s) primarily in cancer.He has been Founder, Chairman and CEO of both private and public companies. He was Founder, Chairman and CEO of BCL labs with operations in the SE, US which was acquired by Corning-Metpath now Quest Diagnostics.He has worked in the laboratory in clinical chemistry, hematology, microbiology, toxicology and immunology; diagnostic test development relating to cancers of the prostate, colon, pancreas, breast and ovary, cytogenetics, flow cytometry, FISH and imaging in digital mammography, fundoscopic analysis of macular degeneration (AMD) and launched the first iPhone App using SVM’s for educational purposes regarding melanoma detection. Dr. Barnhill has executed deals with many companies including Pfizer, Quest Diagnostics, Clarient (now GE Healthcare), LabCorp, NeoGenomics, Abbott and others. He published many papers with academics including those from MD Anderson Cancer Center, Johns Hopkins University, Stanford University Medical Center and others. He is a frequently invited speaker to conferences in the US and internationally.He has raised millions of dollars in start up and on-going financing for private and public companies.Dr. Barnhill is or has been a Member or Fellow of the Am College of Physician Inventors, Am College of Int'l Physicians, AMA, Am College of Physician Executives, the Am Soc of Law, Medicine and Ethics, Society of Cannabis Clinicians Show less

National Medical Specialty Labs was a pioneer in the use of neural networks applied to diagnostic test development. The Company was sold to Horus Therapeutics, a New york based Pharmaceutical Company and the neural network patents were sold to Johnson and Johnson.

Chairman and CEO of Clinical Laboratory specializing in hematology, clinical chemistry, special chemistry, microbiology, drug testing, and genetic testing for hospitals, private physicians, and nursing homes. The Company was sold to Corning/Metpath currently Quest Diagnostics. Dr. Barnhill was a Medical Director for Quest Diagnostics for approximately 5 years after the acquisition.